Baluarte, Janet .
HRN: 12-70-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2024
CEFUROXIME 1.5GM (VIAL)
08/02/2024
08/02/2024
IV
1.5g
PTOR
CS For Preeclampsia With Severe Features
Waiting Final Action
Indication: Prophylaxis Type of Infection: Multiple Infections (tick All Sites)Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes